au.\*:("NICOLAS, Olivier")
Results 1 to 13 of 13
Selection :
Apports de la thermochronologie 40Ar/39Ar sur feldspath potassique à la connaissance de la tectonique cénozoïque d'Asie. Etude des mécanismes d'accomodation de la collision continentale = Bringing of 40Ar/39Ar of potassic feldspars to the knowledge of Asia Cenozoïc tectonicsARNAUD, Nicolas Olivier.1992, 161 p.Thesis
Quantification of antimalarial bisthiazolium compounds and their neutral bioprecursors in plasma by liquid chromatography-electrospray mass spectrometryNICOLAS, Olivier; FARENC, Christine; CALAS, Michèle et al.Clinical chemistry (Baltimore, Md.). 2005, Vol 51, Num 3, pp 593-602, issn 0009-9147, 10 p.Article
Stratégie de validation de méthodes de dosage en bioanalyse en vue d'études pharmacocinétiques et toxicologiques = A strategy for validation of bioanalytical methods to support pharmacokinetic and toxicological studiesNICOLAS, Olivier; FARENC, Christine; BRESSOLLE, Francoise et al.Annales de toxicologie analytique. 2004, Vol 16, Num 2, pp 118-127, issn 0768-598X, 10 p.Article
Description de la charge de soins en séance d'hémodialyse = Workload during hemodialysis sessionsPETERS, Nicolas Olivier; CRIDLIG, Joëlle; LOOS-AYAV, Carole et al.Néphrologie & thérapeutique. 2010, Vol 6, Num 6, pp 526-531, issn 1769-7255, 6 p.Article
In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of TelaprevirMIN JIANG; MANI, Nagraj; MÜH, Ute et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 6236-6245, issn 0066-4804, 10 p.Article
Liquid chromatography-electrospray mass spectrometry determination of a bis-thiazolium compound with potent antimalarial activity and its neutral bioprecursor in human plasma, whole blood and red blood cellsNICOLAS, Olivier; MARGOUT, Delphine; TAUDON, Nicolas et al.Journal of chromatography. B. 2005, Vol 820, Num 1, pp 83-93, issn 1570-0232, 11 p.Article
Evaluation of VCH-759 monotherapy in hepatitis C infectionCOOPER, Curtis; LAWITZ, Eric J; NICOLAS, Olivier et al.Journal of hepatology. 2009, Vol 51, Num 1, pp 39-46, issn 0168-8278, 8 p.Article
HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESYYANNOPOULOS, Constantin G; PING XU; PROULX, Melanie et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 21, pp 5333-5337, issn 0960-894X, 5 p.Article
Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3NICOLAS, Olivier; MARGOUT, Delphine; TAUDON, Nicolas et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3631-3639, issn 0066-4804, 9 p.Article
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: SulfonamidesCHAN, Laval; DAS, Sanjoy K; YANNOPOULOS, Constantin G et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 3, pp 793-796, issn 0960-894X, 4 p.Article
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: Tertiary amidesCHAN, Laval; PEREIRA, Oswy; ROY, Caroline et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 3, pp 797-800, issn 0960-894X, 4 p.Article
Traitements de l'échantillon biologique avant l'analyse chromatographique. Applications à la pharmacocinétique et à la toxicologie = Sample handling and pre-treatment prior to chromatographic analysis. Applications to pharmacokinetics and toxicologyNICOLAS, Olivier; ROBERT, Damien; KELLY, Marie T et al.Annales de toxicologie analytique. 2004, Vol 16, Num 3, pp 199-213, issn 0768-598X, 15 p.Article
Control of hematopoietic stem/progenitor cell fate by transforming growth factor-βFORTUNEL, Nicolas Olivier; HATZFELD, Jacques Alexandre; MONIER, Marie-Noëlle et al.Oncology research. 2003, Vol 13, Num 6-10, pp 445-453, issn 0965-0407, 9 p.Conference Paper